Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing

BACKGROUND: With increasing numbers of oncology biosimilars in the approval pipeline, it is important to investigate oncology clinicians’ understanding of biosimilars and what information they need prior to adoption. METHODS: Between January and May 2018, 77 oncology clinicians (52 physicians, 16 ph...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Med Oncol
Asıl Yazarlar: Cook, John W., McGrath, Megan K., Dixon, Margie D., Switchenko, Jeffrey M., Harvey, R. Donald, Pentz, Rebecca D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327341/
https://ncbi.nlm.nih.gov/pubmed/30671144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918818335
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller